Share This

Related Topics News - Drugs

     
 < Previous page   Detail   |   Print    Next page > 
     
《大行》大和:金斯瑞生物科技今年有望轉盈 降目標價至25元
2025-03-13T  
《大行》中銀國際降金斯瑞目標價至21元 維持「買入」評級
2025-03-13T  
《港股》恆指半日跌158點 長汽及蔚來抽升 內需股回吐
2025-03-12T  
《業績》金斯瑞生物科技去年虧轉盈賺29.62億美元 不派息
2025-03-12T  
《港股》恆指半日升135點 小鵬漲7% 京東系績後軟
2025-03-07T  
國家藥監局:引導企業及研發機構等加大創新藥和高質量仿制藥研發
2025-02-20T  
第十批國家組織藥品集採開標 62種藥品採購成功
2024-12-13T  
內地第十批藥品集中採購即將開標 國採納入62種藥品
2024-12-12T  
《業績》神威藥業首九個月營業額約28.8億人幣 按年跌近17%
2024-11-08T  
《大行》華興證券降神威藥業目標價至18元 每股淨現金接近股價及維持高分紅率
2024-09-04T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.